 1  8 
namely Falcipains (FPs) of P. falciparum and their homologs. P. falciparum has four FPs; 1 0 3 FP-1, FP-2, FP-2' and FP-3. FP-1 is the most conserved protease among the four proteases, 1 0 4 and its role in parasite entry into RBCs is yet to be resolved. Although its inhibition using 1 0 5 specific peptidyl epoxides blocked erythrocyte invasion by merozoites [28] , FP-1 gene 1 0 6 disruption in blood stage parasites does not affect their growth [29, 30] . Despite its biological 1 0 7 function remaining uncertain, FP-2' is biochemically similar to FP-2 and shares 99% 1 0 8 sequence identity [22, 31] . FP-2 (FP-2') and FP-3 share 68% sequence identity and are the 1 0 9 major cysteine proteases involved in hemoglobin degradation in the parasite [32] [33] [34] [35] . Expression of these proteins during the blood stage by plasmodia is strictly regulated in a 1 1 1 site-specific and time-dependent manner [28, 36, 37] . These hemoglobinases have differential 1 1 2 expression timing during the trophozoite stage: the early phase is characterised by FP-2 1 1 3 abundance while FP-3 is abundant at the late stages [17, 22] . It was shown that targeted 1 1 4 disruption of FP-2 gene in plasmodia results in accumulation of undigested hemoglobin in the 1 1 5 food vacuole and its enlargement [17] , therefore the protein can be considered as a promising 1 1 6 drug target [38, 39] . On the other hand, inhibiting individual proteases might not be essential 1 1 7 due to redundancy in the hemoglobin digestion stage [10] , hence any inhibitor design for FPs 1 1 8 should consider blocking the activity of both FP-2 and FP-3. The importance of FP-2 as a 1 1 9 drug target was also indicated in a recent study in which FP-2 polymorphisms were shown 1 2 0 that are associated with artemisinin resistance [40] . Other Plasmodium species also express proteins highly homologous to FP-2 and FP-3 [41- based [31, [54] [55] [56] , non-peptidic [50, [57] [58] [59] [60] [61] and peptidomimetic [58, 62, 63] studies. Hitherto, 1 4 0 none of these inhibitors has been approved as an antimalarial drug as they have limited 1 4 1 selectivity against host cathepsins, homologs to the parasites proteases. To overcome this, 1 4 2 distinctive features between these two classes of proteins must be determined. Primarily, the 1 4 3 current work utilises in silico approaches to characterize FP-2 and FP-3, their homologs from 1 4 4
other Plasmodium species as well as human homologs (cathepsins) to identify sequence, 1 4 5 physicochemical and structure differences that can be exploited for peptide-based 1 4 6 antimalarial drug development. Although the two protein classes share high similarity, 1 4 7 important differences that can be essential for inhibitor selectivity exist [50, 64] Interestingly, there is no significant difference between the aromaticity, GRAVY and 2 8 2 instability index scores of partial zymogen complex and individual catalytic domains either. However, significant differences exist in the molecular weight and isoelectric point (pI).
8 4
Plasmodial partial zymogens have higher molecular weight than that of human cathepsins, as 2 8 5 they have longer sequences (two additional structural catalytic domain inserts and longer 2 8 6 prodomains). A key factor that controls the functioning of cysteine proteases is pH of the 2 8 7 milieu in which they are found. All the plasmodial prodomain-catalytic complexes and Cat-L 2 8 8 have a slightly acidic pI of 5.66 ± 0.37 with their catalytic domains exhibiting lower pI. The other cathepsins have basic pI for both their partial zymogen complexes and catalytic where the plasmodial proteases and Cat-L are found in acidic food vacuoles and lysosomes 2 9 2 respectively while the remaining cathepsins are predominantly found in extracellular matrix. In addition to the previous findings for catalytic domain conservation discussed in detail in 2 9 5 ref [7] , current MSA identified two highly conserved ERFNIN and GNFD motifs, which are 2 9 6 located in the α 2-helix and the adjacent downstream loop region between β turn and α 3-helix subsite residues is shown with filled circles (Red=S1, Blue= S2, Green=S3 and S1'=black). Despite the highly conserved nature of the ERFNIN motif across all the plasmodial proteins in the stability of the partial zymogen complex [84] . In plasmodial proteases, conservative 3 1 5 substitution occurs on these two residues whereby they are replaced by less hydrophobic Phe interactions with subsites S2 and S1' residues" section. MSA result also revealed that which is absent in the plasmodial proteases, and its importance is yet to be reported. Phylogenetic analysis using partial zymogen sequences gave a distinct clustering between 3 2 2 plasmodial proteins and human cathepsins forming two separate clades ( Figure 5 ). There is 3 2 3 no notable difference in tree topology in analysis performed using the catalytic domains only. This can be explained by the observed low sequence identity in both partial zymogen ( Table   3 2 5 1) and catalytic domain sequences between the two groups of proteins [50] . The plasmodial 3 2 6
proteases further clustered into two main subgroups based on the host. This is attributed to 3 2 7 the previously reported sequence variations between the human and rodent plasmodial proteases possibly due to the high sequence similarity between the two proteins. The rate of 3 3 0 mutation accumulation appears to vary between the two classes of proteins, being slowest in 3 3 1 the human cathepsins. All human plasmodial proteases seem to evolve at the same rate as Sequence motifs within proteins might be associated with a specific biological function. Thus distributions were identified in the set of proteins studied ( Figure 6A ). These motifs were 3 4 8 then mapped onto the 3D structures of partial zymogen complexes ( Figure 6B and 6C). Five Out of these five motifs, M1, M3, M5 and M7 are located at the catalytic domain of all showing the location of all motifs within the prodomain-catalytic structural fold. Labelled in motifs had no defined function assigned to them according to these webservers. and S1' residues 3 7 5
Different non-canonical interactions were identified between the prodomain and catalytic 3 7 6
domain of proteins. These included hydrophobic, cation-π, ionic, aromatic-aromatic and 3 7 7
hydrogen bonds. In all partial zymogen complexes studied, no disulphide linkages between hydrogen bonds, which participated either in anchoring and maintaining the folding integrity 3 8 0 of the prodomain segment, or in mediating its inhibitory effect by interacting with subsite 3 8 1 residues (Table S4 ). Our residue interaction results revealed that prodomain anchoring Trp while the fourth position has charged residue substitution (Arg) resulting in weak 3 9 5
interactions. A strong residue interaction network between the ERFNIN-GNFD motifs exists 3 9 6 in all proteins, confirming the importance of these two motifs in the stability of the 3 9 7
prodomain. interacting with non-subsite residues (grey spheres) while sticks are prodomain residues 4 0 2
interacting with subsite residues: S1 (red), S2 (blue), S3 (green) and S1' (cyan). Orange with Glu220 (-9.5 kJ/mol). To validate these results, Asp216 and Glu220 were independently salt bridge was most likely formed by these residues. In addition, the mutagenesis study 4 2 7
identified aromatic-aromatic interactions in FP-2 between Phe214, Trp449 and Trp453 to be 4 2 8 also important in the activation. These residues were conserved in all proteins and formed 4 2 9 strong interactions, an indication that they are of functional importance as in FP-2.
3 0
A specific aim of this study was to determine the responsible residues that confer the mostly interact with subsite S2 and S1' residues via hydrophobic interactions and hydrogen 4 3 6
bonds (Table S4 ). This correlates to our previous findings where residues forming these two 4 3 7
subsites were found to be critical in the inhibitory effect and selectivity using non-peptide subsites of the different proteins is observed (Figure 8 ). For subsite S1, a limited residue 4 4 6 contact network was observed mainly with residues located at the α 3-helix in all the 4 4 7
proteases. The C-terminal end of prodomain segment mainly exhibits contacts with S2 and S3 interactions than the human plasmodial counterparts. In our previous study, high residue 4 5 0 variation across the proteins in S2 as well as S1'subsites was reported [50] . In all the proteins, 4 5 1 the first three prodomain inhibitory segment amino acids form strong hydrophobic contacts 4 5 2 with residues at the opening of S1' subsite ( Figure 8 ). Rodent plasmodial proteases have 4 5 3 additional hydrogen bonding network, due to presence of charged residues at the fourth or 4 5 4 fifth S1' position. From the interaction energy results, there are no observable contacts 4 5 5
between residues Ala218 to Thr221 (FP-2 numbering) with any of the proteins' subsite 4 5 6
residues. However, a strong hydrogen bonding network is formed between prodomain 4 5 7
Ser231, Leu232, Arg233 with Leu429, Asn430 (S2), Val406, Ala412 (S1') and Gly334-335 trend with other plasmodial proteases was observed ( insights. For FP-2, three peptide studies based on its prodomain-catalytic domain interaction length and molecular mass, the therapeutic potential of this peptide is uncertain.
8 5
In our study, peptides aimed at mimicking the inhibitory prodomain segment were designed conservation of the prodomain segments responsible for the inhibitory mechanism for all the 4 8 9
proteases was selected for docking against the catalytic domains of individual proteins using 4 9 0 the CABS-dock webserver (Figure 9 ). CABS-dock performs blind docking simulations to affinity scores with peptide 1, no differential binding was observed with the human 4 9 7 cathepsins. As its N-terminus had highly conserved GNFD motif residues responsible for 4 9 8
anchoring and maintaining the prodomain integrity, we chose to find out if a shorter peptide to peptide 1 and lacked differential binding affinity profile between the two protein classes. WebLogo server. Actual residue numbering per protein is given on the side. unselective high affinity binding on both human cathepsins and plasmodial proteases, stronger interactions with the catalytic subsite residues were also taken into account.
2 5
However, the Δ G between peptide 3 and plasmodial proteases was significantly lower in peptide, similar to peptide 4 except for its length, (EFKNKYLTLKSKD) was also evaluated.
3 3
The residues in this peptide showed some conservation in the plasmodial proteases and had 5 3 4 significant differences to the human cathepsins. Interestingly, it bound more strongly to all 5 3 5
plasmodial proteases compared to the human cathepsins. A likely explanation of this 5 3 6 differential binding affinity was that the peptide interacted with fewer residues on human 5 3 7 cathepsins compared to the plasmodial proteins ( Figure 10) . In most of the plasmodial 5 3 8
proteases, peptide 5 bound with almost same affinity as that of chagasin and FP-2 (-11.9 5 3 9 kcal/mol). From the prodomain-catalytic interaction analysis (Table 5 and Figure 10) , the subsite residues thus forming a stronger complex. In most plasmodial proteases, peptide 5 5 4 3
formed multiple hydrogen bonds especially with S2 and S1' subsite residues. These two 5 4 4
subsites residues have been found to be key in determining binding selectivity as they are the main contributors to ligand binding [50] . Docking studies with previously modelled catalytic 5 4 6
domains gave results consistent with the current models. (Red=S1, Blue=S2, Cyan=S3, S1'=orange and Magenta=catalytic residues). From the motif analysis ( Figure 6 ), a large proportion of peptide 5 was represented in motif inhibitors as potential therapeutics for resistant strains of malaria: a patent review. T  a  b  l  e  3  .  A  s  u  m  m  a  r  y  o  f  p  h  y  s  i  c  o  c  h  e  m  i  c  a  l  p  r  o  p  e  r  t  i  e  s  o  f  F  P  -2  a  n  d  F  P  -3  a  n  d  h  o  m  o  l  o  g  s  p  a  r  t  i  a  l  z  y  m  o  g  e  n  8  7  3   s  eu  e  n  c  e  s  .  I  n  c  l  u  d  e  d  a  l  s  o  a  r  e  p  r  o  p  e  r  t  i  e  s  w  h  e  r  e  c  a  t  a  l  y  t  i  c  d  o  m  a  i  n  s  i  g  n  i  f  i  c  a  n  t  l  y  v  a  r  i  e  d  f  r  o  m  p  a  r  t  i  a  l  8  7 1.2E-06 -9 2.7E-07 -11.4 4.4E-09 FP-3 -12.2 1.2E-09 -10.5 2.0E-08 -9.6 9.4E-08 -9.7 7.8E-08 -12.3 8.8E-10 VP-2 -11.0 8.3E-09 -10.1 3.8E-08 -12.3 8.8E-10 -9.0 2.7E-07 -10.9 1.1E-08 VP-3 -11.7 2.7E-09 -11.0 8.3E-09 -9.9 5.7E-08 -9.2 1.7E-07 -11.8 2.1E-09 KP-2 -12.7 4.7E-10 -11.8 2.1E-09 -6.7 1.3E-05 -8.1 1.2E-06 -10.6 1.8E-08 KP-3 -11.8 2.1E-09 -12.7 5.2E-10 -9.3 1.4E-07 -9.2 1.9E-07 -12.7 5.2E-10 BP-2 -11.5 3.7E-09 -12.2 1.2E-09 -10.9 9.9E-09 -7.9 1.7E-06 -11.7 2.7E-09 CP-2 -11.9 2.2E-09 -11.7 2.7E-09 -8.7 3.9E-07 -8.3 1.1E-07 -12.7 4.7E-10 YP-2 -11.7 2.7E-09 -14.3 5.5E-11 -12.4 7.9E-10 -10.4 2.5E-08 -9.3 1.5E-07 Cat-K -13.9 6.3E-11 -11.5 3.5E-09 -11.9 2.0E-09 -11.4 4.2E-09 -8.3 1.1E-07 Cat-L -12.2 1.0E-09 -11.8 5.1E-09 -12.3 9.7E-10 -10.2 3.5E-08 -8.7 9.2E-07 Cat-S -10.4 2.4E-09 -11.5 3.5E-09 -12.4 7.7E-10 -9.9 5.2E-08 -8.6 4.8E-07 
